Search results

Evidence-based recommendations on liraglutide (Saxenda) for managing overweight and obesity alongside a reduced-calorie diet and increased physical activity in adults.

Result type

Technology appraisal guidance

Published

9 December 2020

Evidence-based recommendations on dexamethasone intravitreal implant (Ozurdex) for treating macular oedema following retinal vein occlusion in adults.

Result type

Technology appraisal guidance

Published

27 July 2011

Evidence-based recommendations on dapagliflozin (Forxiga) given with other drugs for treating type 2 diabetes in adults.

Result type

Technology appraisal guidance

Last updated

23 November 2016

Evidence-based recommendations on nintedanib (Ofev) for adults with idiopathic pulmonary fibrosis.

Result type

Technology appraisal guidance

Published

27 January 2016

Evidence-based recommendations on bevacizumab (Avastin) and cetuximab (Erbitux) for treating metastatic colorectal cancer in adults.

Result type

Technology appraisal guidance

Last updated

1 January 2012

Evidence-based recommendations on glycoprotein IIb/IIIa inhibitors (abciximab, eptifibatide, tirofiban) for treating acute coronary syndromes in adults.

Result type

Technology appraisal guidance

Last updated

1 March 2010

Evidence-based recommendations on cannabidiol (Epidyolex) for treating seizures caused by tuberous sclerosis complex.

Result type

Technology appraisal guidance

Published

1 March 2023

Evidence-based recommendations on polatuzumab vedotin (Polivy) with rituximab, cyclophosphamide, doxorubicin and prednisolone for untreated diffuse large B-cell lymphoma in adults.

Result type

Technology appraisal guidance

Published

1 March 2023

Evidence-based recommendations on semaglutide (Wegovy) for managing overweight and obesity in adults.

Result type

Technology appraisal guidance

Last updated

4 September 2023

Evidence-based recommendations on finerenone (Kerendia) for stage 3 and 4 chronic kidney disease (with albuminuria) associated with type 2 diabetes in adults.

Result type

Technology appraisal guidance

Published

23 March 2023

Evidence-based recommendations on nivolumab (Opdivo) with chemotherapy for neoadjuvant treatment of resectable non-small-cell lung cancer in adults.

Result type

Technology appraisal guidance

Published

22 March 2023

Evidence-based recommendations on raloxifene and teriparatide for preventing osteoporotic fragility fractures in postmenopausal women who have osteoporosis.

Result type

Technology appraisal guidance

Last updated

7 February 2018

Evidence-based recommendations on trastuzumab for treating advanced breast cancer in adults.

Result type

Technology appraisal guidance

Published

15 March 2002

NICE is unable to make a recommendation on slow-release potassium bicarbonate–potassium citrate (Sibnayal) for treating distal renal tubular acidosis in people 1 year and over. This is because Advicenne withdrew its evidence submission.

Result type

Technology appraisal guidance

Published

2 November 2022

Evidence-based recommendations on raloxifene for the primary prevention of osteoporotic fragility fractures in postmenopausal women.

Result type

Technology appraisal guidance

Last updated

7 February 2018